bosentan anhydrous has been researched along with beta-Thalassemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthi, A; Armaganidis, A; Hamodraka, ES; Lekakis, J; Orfanos, SE; Tsangaris, I | 1 |
| Casset-Sedon, D; Cosnay, P; Maillot, F; Pierre, B; Regina, S; Sitbon, O | 1 |
2 other study(ies) available for bosentan anhydrous and beta-Thalassemia
| Article | Year |
|---|---|
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.
Topics: Antihypertensive Agents; beta-Thalassemia; Bosentan; Female; Humans; Hypertension, Pulmonary; Middle Aged; Pulmonary Artery; Sulfonamides | 2012 |
[Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy].
Topics: Antihypertensive Agents; beta-Thalassemia; Bosentan; Chronic Disease; Humans; Iron Overload; Male; Middle Aged; Pulmonary Embolism; Splenectomy; Sulfonamides; Treatment Outcome | 2006 |